GIL Gildan Activewear Inc. IFRS Annual reports only
Apparel & Other Finishd Prods of Fabrics & Similar Matl · NYSE · SEC CIK 1061894 · Fiscal year ends 01/03
Financial factors as of 2025-12-28 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-28 | FY20242024-12-29 | FY20232023-12-31 | FY20222023-01-01 | FY20222022-01-02 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.62B | $3.27B | $3.20B | $3.24B | $2.92B |
| Cost of revenue | $2.49B | $2.27B | $2.32B | $2.25B | $1.98B |
| Gross profit | $1.13B | $1.00B | $880.05M | $992.41M | $940.21M |
| SG&A expense | $389.35M | $390.77M | $330.39M | $326.26M | $314.17M |
| Operating income | $619.94M | $618.24M | $643.85M | $603.38M | $651.89M |
| Pretax income | $471.19M | $514.09M | $564.18M | $566.43M | $624.56M |
| Income tax | $77.26M | $113.22M | $30.60M | $24.89M | $17.38M |
| Net income | $398.88M | $400.87M | $533.58M | $541.54M | $607.18M |
| EBITDA | $767.50M | $756.44M | $765.50M | $728.31M | $787.29M |
| EPS (basic) | 2.61 | 2.46 | 3.03 | 2.94 | 3.08 |
| EPS (diluted) | 2.61 | 2.46 | 3.03 | 2.93 | 3.07 |
| Weighted avg. shares (diluted) | 153.07M | 163.18M | 176.22M | 184.53M | 197.59M |
| Balance sheet | |||||
| Cash & equivalents | $284.46M | $98.80M | $89.64M | $150.42M | $179.25M |
| Receivables | $955.67M | $542.36M | $412.50M | $248.78M | $329.97M |
| Inventory | $2.37B | $1.11B | $1.09B | $1.23B | $774.36M |
| Current assets | $4.71B | $1.86B | $1.69B | $1.73B | $1.45B |
| PP&E, netmay include right-of-use assets (IFRS) | $1.47B | $1.17B | $1.17B | $1.12B | $985.07M |
| Goodwill | $868.85M | $271.68M | $271.68M | $271.68M | $283.81M |
| Intangibles | $3.02B | $253.32M | $253.32M | $261.42M | $229.95M |
| Total assets | $10.47B | $3.72B | $3.51B | $3.44B | $3.14B |
| Current liabilities | $2.24B | $837.49M | $724.09M | $641.67M | $463.60M |
| Short-term debt | $450.00M | $300.00M | $300.00M | $150.00M | $0 |
| Long-term debt | $3.86B | $1.24B | $685.00M | $780.00M | $600.00M |
| Total debt | $4.31B | $1.54B | $985.00M | $930.00M | $600.00M |
| Total liabilities | $6.90B | $2.26B | $1.56B | $1.56B | $1.22B |
| Shareholders' equity | $3.56B | $1.46B | $1.96B | $1.88B | $1.92B |
| Net debt | $4.03B | $1.44B | $895.36M | $779.58M | $420.75M |
| Shares outstanding | 185.15M | 152.41M | 169.99M | 179.71M | 192.27M |
| Cash flow statement | |||||
| Operating cash flow | $606.32M | $501.39M | $546.61M | $413.49M | $617.51M |
| Capital expenditure | $106.44M | $145.33M | $203.29M | $239.13M | $127.46M |
| Free cash flow | $499.88M | $356.06M | $343.32M | $174.36M | $490.05M |
| Investing cash flow | -$236.00M | -$112.12M | -$154.86M | -$182.40M | -$187.83M |
| Financing cash flow | -$177.06M | -$379.35M | -$452.78M | -$258.27M | -$754.75M |
| Depreciation & amortization | $147.57M | $138.20M | $121.64M | $124.93M | $135.40M |
| Stock-based compensation | $47.95M | $64.53M | $26.96M | $32.39M | $37.66M |
| Dividends paid | $135.24M | $133.47M | $131.80M | $123.77M | $90.46M |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.